Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Sell
5,180
-1,373
-21% -$2.19M 3.79% 4
2026
Q1
$8.65M Sell
6,553
-1,941
-23% -$2.66M 3.22% 8
2025
Q4
$9.09M Sell
8,494
-65
-0.8% -$67.8K 3.42% 3
2025
Q3
$8.29M Sell
8,559
-92
-1% -$72.3K 3.21% 4
2025
Q2
$6.93M Buy
8,651
+6,050
+233% +$4.34M 2.72% 10
2025
Q1
$1.72M Buy
2,601
+304
+13% +$221K 2.06% 25
2024
Q4
$1.59M Buy
+2,297
New +$1.65M 1.89% 30

Other funds holding ASML

Martin Capital Partners's ASML Position: Q2 2026 in Review

Martin Capital Partners reduced its ASML (ASML) stake by 21% in Q2 2026, selling an estimated $2.19M and leaving 5,180 shares worth $10.3M. The position accounts for 3.79% of the portfolio, ranked #4.

Martin Capital Partners first reported a position in ASML in Q4 2024 and has held it in 7 quarters since. 2,501 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Martin Capital Partners held 5,180 shares of ASML worth $10.3M as of Q2 2026.
  • Martin Capital Partners sold 1,373 ASML shares in Q2 2026, an estimated $2.19M.
  • ASML made up 3.79% of Martin Capital Partners's portfolio in Q2 2026, its #4 holding.
  • Martin Capital Partners first reported a position in ASML in Q4 2024 and has held it in 7 quarters since.
  • 2,501 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Martin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.